Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Iteos Therapeutics, Inc. (ITOS)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 37,960,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   iTeos Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of a differentiated immuno-oncology therapeutics for patients. Co.'s product candidate, inupadenant, is designed as a selective small molecule antagonist of the adenosine A2a receptor, in the adenosine pathway, a main driver of immunosuppression in the tumor microenvironment across a range of tumors. Co.'s main antibody product candidate, EOS-448, is an antagonist of T-cell immunoreceptor with Ig and ITIM domains, an immune checkpoint with multiple mechanisms of action leading to immunosuppression.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 5,000 5,000
Total Buy Value $0 $0 $41,850 $41,850
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 350,000 379,615
Total Sell Value $0 $0 $5,692,673 $6,289,886
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 1 3
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 227
  Page 7 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-09-20 4 AS $27.03 $1,117,964 I/I (40,673) 5,576,212     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-09-20 4 AS $27.03 $668,008 I/I (24,303) 3,397,322     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-09-17 4 AS $28.82 $1,317,016 I/I (45,698) 3,421,625     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-09-17 4 AS $28.82 $2,203,952 I/I (76,473) 5,616,885     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-09-17 4 AS $28.82 $1,317,016 I/I (45,698) 3,421,625     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-09-16 4 AS $28.47 $605,073 I/I (21,253) 3,467,323     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-09-16 4 AS $28.47 $1,012,536 I/I (35,565) 5,693,358     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-09-16 4 AS $28.47 $605,073 I/I (21,253) 3,467,323     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-09-15 4 AS $27.79 $670,207 I/I (24,104) 3,488,576     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-09-15 4 AS $27.79 $1,121,535 I/I (40,336) 5,728,923     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-09-15 4 AS $27.79 $670,207 I/I (24,104) 3,488,576     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-09-14 4 AS $27.50 $594,703 I/I (21,561) 3,512,680     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-09-14 4 AS $27.50 $995,198 I/I (36,081) 5,769,259     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-09-14 4 AS $27.50 $594,703 I/I (21,561) 3,512,680     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-09-13 4 AS $27.64 $591,054 I/I (21,384) 3,534,241     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-09-13 4 AS $27.64 $591,054 I/I (21,384) 3,534,241     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-09-13 4 AS $27.64 $989,097 I/I (35,785) 5,805,340     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-09-10 4 AS $27.86 $382,864 I/I (13,531) 3,555,625     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-09-10 4 AS $27.86 $382,864 I/I (13,531) 3,555,625     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-09-10 4 AS $27.86 $640,691 I/I (22,643) 5,841,125     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-09-09 4 AS $28.97 $658,343 I/I (22,725) 3,569,156     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-09-09 4 AS $28.97 $658,343 I/I (22,725) 3,569,156     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-09-09 4 AS $28.97 $1,101,671 I/I (38,028) 5,863,768     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-09-08 4 AS $28.61 $579,723 I/I (20,236) 5,901,796     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-09-08 4 AS $28.61 $346,413 I/I (12,092) 3,591,881     -
  227 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us